Centrus Unveils Major Expansion: First New U.S. Uranium Enrichment Capacity in Decades
Centrus Energy (NYSE: LEU) has announced a transformative leap for the U.S. nuclear industry: it has started domestic centrifuge manufacturing to support commercial Low-Enriched Uranium (LEU) enrichment at its Piketon, Ohio, facility. This marks the nation’s largest move toward domestic uranium enrichment since the 1950s—a major pivot as the U.S. seeks to rebuild nuclear self-reliance in the face of shifting geopolitical realities and a growing demand for clean energy.
Expansion Backed by Multi-Billion-Dollar Customer Commitments and Federal Support
At the heart of this initiative is Centrus’ $2.3 billion backlog in contingent LEU sales to U.S. and international customers. The company also secured more than $1.6 billion in cash as of September 2025 and completed convertible note offerings totaling $1.2 billion in the past year. Centrus is currently a finalist for high-profile Department of Energy (DOE) contracts, each potentially worth up to $900 million, providing further momentum from the public sector.
| Funding Source | Detail | Amount (USD) |
|---|---|---|
| Customer Contracts | Contingent sales to U.S. & Int'l customers | $2.30 Billion |
| Convertible Notes | Raised November 2024 & August 2025 | $1.20 Billion |
| Cash Reserves | As of September 2025 | $1.60 Billion |
| Potential DOE Task Orders | Per Task Order | $900 Million |
Project Timelines and Economic Impact: Thousands of U.S. Jobs Will Be Created
Centrus has already begun hiring to support the industrial-scale centrifuge manufacturing effort, with the first new capacity expected online by 2029. The initiative will support 1,000 construction jobs, add 300 operating positions in Ohio, and expand Centrus’ Tennessee manufacturing, driving ripple effects across the supply chain. Indirectly, the project is expected to catalyze thousands of jobs nationwide.
Strategic Significance: Reducing Foreign Dependence and Bolstering National Security
This expansion comes at a pivotal time: since the closure of the last major U.S.-owned enrichment plant in 2013, America has been nearly 100% dependent on foreign (primarily state-owned) uranium enrichment. With imports of Russian enriched uranium banned after 2028 and growing international demand for clean energy, Centrus’ U.S.-origin AC100M centrifuge stands as the only deployment-ready technology to serve domestic needs—a clear edge in national security and competitiveness.
Investor Takeaways: Unique Positioning Amid Surging Demand for Nuclear Energy
With multi-billion-dollar contracts, advances in federal support, and partnerships like the recent one announced with Korea Hydro & Nuclear Power and POSCO, Centrus is positioned at the epicenter of the next wave in nuclear energy growth. Investors and stakeholders may want to watch for pivotal updates on DOE funding, milestone achievements at the Piketon site, and further customer commitments in 2024 and beyond. If capacity comes online as planned in 2029, Centrus could stand as not only a technical and national security leader, but also as a potential bellwether of American nuclear resurgence.
| Key Project Metrics | Figure |
|---|---|
| Current Stock Price (as of 10:35 AM) | $271.64 |
| First New Capacity Online | 2029 (Projected) |
| Contingent LEU Sales Backlog | $2.30 Billion |
| Total Potential DOE Contracts | $900 Million (ea.) |
| Direct New Construction Jobs (Ohio) | 1,000 |
| Operating Jobs (Ohio) | 300 (plus 150 retained) |
What’s Next: Monitoring Key Milestones
While Centrus’ vision is ambitious and progress to date is strong, execution will be key. Watch for updates on project milestones, federal contract awards, and the evolution of supply chain partnerships. As international nuclear policy evolves, Centrus could become a critical player in defining America’s energy and security landscape for years to come.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI